Pregnancy and Menopause in Psychiatry (Apil)

Date of Issue: 04/01/2007 | Volume: 5 | Number: 4

Issue Links:Learning Objectives | Editorial Information

Teaser to be posted soon.

In This Issue

Article

Psychotropics and Pregnancy: A 2007 Update

Topics: Women's Issues in Psychiatry

Every month seems to bring a new FDA advisory or an alarming research finding about the use of medications in pregnancy. In this article, we update you on what we consider to be the most important developments over the past couple of years.

Read More
Article

Prescribing Medications during Pregnancy and Breastfeeding

Topics: Women's Issues in Psychiatry

Over the last several years, we’ve all seen many FDA warnings and cautionary letters from drug companies about the effects of psychotropics in pregnancy. As a result, it’s easy to become a little skittish about prescribing any medication for pregnant women.

Read More
Expert QA

Treating Depression in Perimenopause

Topics: Depressive Disorder | Women's Issues in Psychiatry

Dr. Brizendine, as the director of the UCSF Women’s Mood and Hormone Clinic, you receive many referrals of women who are having difficulty with menopause. What are the typical problems that women have during this period?

Read More
Research Update

Provigil for the Masses?

Provigil (modafinil) is FDA approved for excessive sleepiness due to various causes. An ADHD indication was rejected because of its possible association with a single case of Stevens-Johnson syndrome.

Read More
Research Update

Does “California Rocket Fuel” Work?

Topics: Antidepressants

The combination of Effexor (venlafaxine) and Remeron (mirtazapine) has been dubbed “California Rocket Fuel” by Stephen Stahl (see page 290 of his Essential Psychopharmacology, 2nd Edition) because of the multiple ways the combination boosts various neurotransmitter systems.

Read More
Research Update

What Are the Stages of Grief?

A widely cited sequence of reactions following the death of a loved one includes: disbelief, yearning (for the loved one’s return), anger, depression/mourning, and acceptance. Researchers conducted a study aimed at empirically assessing whether these stages actually occur and, if so, in what order.

Read More
Research Update

Vyvanse Approved for ADHD

Topics: ADHD

On February 23, the FDA approved Shire and New River’s Vyvanse (lisdexamfetamine dimesylate) for the treatment of ADHD in children. Vyvanse is the molecule dextroamphetamine (trade names Dexedrine and Dextrostat) attached to the amino acid lysine.

Read More